Silver Book Fact

1 and 6-month mortality rates without treatment for sSAS

Waiting for treatment for severe symptomatic aortic stenosis (sSAS) can be deadly, with 1-month mortality at 3.7% and 6-month mortality at 11.6% (measured from the time intervention was recommended).

Malaisrie C, McDonald E, Kruse J, et al. Mortality While Waiting for Aortic Valve Replacement. The Annals of Thoracic Surgery. 2014; 98. http://www.annalsthoracicsurgery.org/article/S0003-4975(14)01324-1/pdf

Reference

Title
Mortality While Waiting for Aortic Valve Replacement
Publication
The Annals of Thoracic Surgery
Publication Date
2014
Authors
Malaisrie C, McDonald E, Kruse J, et al
URL
Read Full Resource

Categories

  • Cost of Disease
  • Human Burden

Connected Facts

Related Facts

  • 2016 prevalence of Americans 65+ who had AVD
    In 2016, an estimated 5.2 million U.S. adults ages 65+ had aortic valve disease (AVD).   Note: Alliance for Aging Research generated statistic, based on 2005 percentage prevalence estimates by Bach et al. 2007  
  • Projections of Significant Heart Valve Disease — Diagnosed & Undiagnosed — in the 65+ U.K. Population
     
  • SAS patient hospitalization costs
    Symptomatic aortic stenosis (SAS) patients who do not undergo treatment cost Medicare as much as $1.3 billion each year due to rehospitalization, prolonged stays, admissions to skilled nursing facilities, and…  
  • Survival Rates Over 5 Years for Patients with Medically Managed Severe Aortic Stenosis
     
  • Survival rates for patients with sSAS without repair or replacement